Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board has granted service connection for the cause of death due to acute myelogenous leukemia (AML) related to presumed in-service exposure to Agent Orange. The claim for DIC under 38 U.S.C.A. § 1318 is dismissed as moot.

The deciding factor: The AML that contributed to the Veteran's death was related to his presumed in-service exposure to Agent Orange, which constitutes a service-connected disability for purposes of DIC benefits.

Claimed conditions
Acute Myelogenous Leukemia (AML), Renal Dysfunction, Posttraumatic Stress Disorder (PTSD)
How they argued it
Presumptive (no nexus needed)
Exposure basis
Agent Orange / herbicides
Rating assigned
None in this decision
Decision date
March 14, 2012
Citation
1209527

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1209527.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.